These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 7170150

  • 1. [Pharmacokinetics of orally administered furosemide in children with nephrotic syndrome].
    Prandota J.
    Pediatr Pol; 1982; 57(9):711-8. PubMed ID: 7170150
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
    Prandota J.
    Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
    González-Martín G, Bravo I, Ibarra N, Arancibia A.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children.
    Prandota J.
    Dev Pharmacol Ther; 1982 Dec; 5(1-2):98-108. PubMed ID: 7151641
    [Abstract] [Full Text] [Related]

  • 6. Furosemide disposition in cirrhotic patients.
    Sawhney VK, Gregory PB, Swezey SE, Blaschke TF.
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Encephalopathy after furosemide use in nephrotic syndrome.
    Sharma AP, Grimmer J.
    J Paediatr Child Health; 2007 Mar; 43(3):188-90. PubMed ID: 17316196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Saturable first-pass kinetics, plasma protein binding, and the furosemide intricacies.
    Keller F.
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S24-6. PubMed ID: 7781201
    [Abstract] [Full Text] [Related]

  • 12. Microscopic nephrocalcinosis and hypercalciuria in nephrotic syndrome.
    Mocan H, Yildiran A, Camlibel T, Kuzey GM.
    Hum Pathol; 2000 Nov; 31(11):1363-7. PubMed ID: 11112210
    [Abstract] [Full Text] [Related]

  • 13. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
    Goszczyk A, Jung A, Bochniewska V, Straz-Zebrowska E.
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():25-6. PubMed ID: 11081338
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of nephrotic syndrome.
    Gulati S, Kher V, Elhence R, Kumar P, Sharma RK, Gupta A.
    Indian Pediatr; 1994 Feb; 31(2):165-70. PubMed ID: 7875840
    [Abstract] [Full Text] [Related]

  • 18. [Biological availability of tryptophan in children with nephrotic syndrome].
    Fydryk J, Szuba W, Kurzawska O, Zielazkowska G.
    Pediatr Pol; 1987 Aug; 62(8):529-34. PubMed ID: 3431963
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K.
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.